Expanded Access Programs | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

45,550 results for “Expanded Access Programs”

Trials

View all 29257 →

Viracept Expanded Access Program

First posted Aug 31, 2001

Approved For Marketing

Sapropterin Expanded Access Program

First posted Jun 12, 2007

TETRAVI Expanded Access Program

First posted Aug 5, 2025

Drugs

View all 580 →

Treg programs

AP-2011

Neoantigen-expanded cell

Organizations

View all 91 →

Turning Point Community Programs

United States

Access Vascular, Inc.

United States

Access Business Group LLC

United States

News

View all 15622 →

Expanded Access Programs: Bridging the Gap Between Clinical Trials and Patient Need

AI Platform Connects Nearly 300 Duchenne Patients to Clinical Trials and Expanded Access Programs

FDA Authorizes Expanded Access Programs for Jaguar Health's Crofelemer in Rare Pediatric Intestinal Disease

Page 1 of 4555